Heart rate control as a marker of beta-blocker efficacy in hospitalized heart failure patients

被引:0
|
作者
Owens, Ryan E. [1 ]
Self, Timothy [2 ]
Twilla, Jennifer [3 ]
Cummings, Carolyn [3 ]
Oliphant, Carrie S. [3 ]
机构
[1] Univ Tennessee, Ctr Hlth Sci, Dept Pharm, Methodist Univ Hosp, Memphis, TN 38163 USA
[2] Univ Tennessee, Ctr Hlth Sci, Coll Pharm, Memphis, TN 38163 USA
[3] Methodist Univ Hosp, Dept Pharm, Memphis, TN USA
来源
PHARMACOTHERAPY | 2016年 / 36卷 / 12期
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
12
引用
收藏
页码:E208 / E208
页数:1
相关论文
共 50 条
  • [31] Beta-blocker therapy in heart failure in the elderly
    Fu, Michael
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2008, 125 (02) : 149 - 153
  • [32] Bucindolol: A beta-blocker for the treatment of heart failure
    Reinhart, Kurt M.
    White, C. Michael
    FORMULARY, 2009, 44 (06) : 166 - 171
  • [33] HIGHER BETA-BLOCKER DOSE VERSUS LOWER HEART RATE IN PATIENTS WITH HEART FAILURE DUE TO SYSTOLIC DYSFUNCTION
    Ajam, Tarek
    Ajam, Samer
    Devaraj, Srikant
    Sawada, Stephen
    Kamalesh, Masoor
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 666 - 666
  • [34] EFFECTS OF BETA-BLOCKER ON HEART RATE REDUCTION AND COLLAGEN DEGRADATION IN PATIENTS WITH HEART FAILURE REDUCED EJECTION FRACTION
    Fukui, Miho
    Hirotani, Shinichi
    Goda, Akiko
    Masaki, Mitsuru
    Nakabo, Ayumi
    Fujiwara, Shohei
    Sugahara, Masataka
    Lee-Kawabata, Masaaki
    Masuyama, Tohru
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (10) : E687 - E687
  • [35] Is Target Dose of Beta-Blocker More Important Than Achieved Heart Rate or Heart Rate Change in Patients with Systolic Chronic Heart Failure?
    Porapakkham, Pornwalee
    Porapakkham, Pramote
    Krum, Henry
    CARDIOVASCULAR THERAPEUTICS, 2010, 28 (02) : 93 - 100
  • [36] Assessing Eligibility for Ivabradine Therapy and Beta-Blocker Dose Uptitration in Patients Recently Hospitalized with Heart Failure
    Perez, Antonio L.
    Kittipibul, Veraprapas
    Tang, W. H. Wilson
    Starling, Randall C.
    JOURNAL OF CARDIAC FAILURE, 2016, 22 (08) : S37 - S37
  • [37] Is Target Dose of Beta-blocker More Important Than Achieved Heart Rate or Heart Rate Change in Patients With Systolic Chronic Heart Failure?
    Porapakkham, Pornwalee
    Porapakkham, Pramote
    Krum, Henry
    CIRCULATION, 2009, 120 (18) : S540 - S541
  • [38] Clinical outcomes with digoxin vs. beta-blocker for heart rate control in permanent atrial fibrillation with heart failure
    Bisson, Arnaud
    Ding, Wern Y.
    Bodin, Alexandre
    Lip, Gregory Y. H.
    Fauchier, Laurent
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 (09) : 1563 - 1565
  • [39] The Role of Beta-Blocker in Heart Failure in Adults with Congenital Heart Disease
    Norozi, Kambiz
    REVIEWS ON RECENT CLINICAL TRIALS, 2014, 9 (02) : 64 - 67
  • [40] Compound genotypes associated with beta-blocker efficacy in congestive heart failure are common
    Lanfear, DE
    Marsh, S
    McLeod, HL
    JOURNAL OF CARDIAC FAILURE, 2004, 10 (04) : S57 - S57